SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 104.69   5.42 (+5.46%) Volume: 849k 4:00 PM EDT 19-Sep-2019
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KReport of unscheduled material events or corporate changes.404/22/2019
SC 13GStatement of beneficial ownership of common stock by certain persons504/15/2019
4Statement of changes in beneficial ownership of securities103/15/2019
4Statement of changes in beneficial ownership of securities103/15/2019
4Statement of changes in beneficial ownership of securities103/15/2019
8-KReport of unscheduled material events or corporate changes.20503/12/2019
8-KReport of unscheduled material events or corporate changes.803/06/2019
8-KReport of unscheduled material events or corporate changes.5203/05/2019
10-KAnnual report with a comprehensive overview of the company14302/28/2019
4Statement of changes in beneficial ownership of securities102/13/2019
4Statement of changes in beneficial ownership of securities102/13/2019
4Statement of changes in beneficial ownership of securities102/13/2019
4Statement of changes in beneficial ownership of securities102/13/2019
SC 13G/AAmendment to the SC 13G filing502/13/2019
SC 13GStatement of beneficial ownership of common stock by certain persons102/12/2019
123456789101112131415